The number of manufacturers, product specifications, and output of the pharmaceutical equipment industry in China have ranked first in the world and become a veritable pharmaceutical equipment power. However, there is still a big gap between quality and technology compared with international advanced countries and regions. It should be said that the state has implemented the GMP certification system for pharmaceutical production enterprises, which has provided a great space for the development of the pharmaceutical equipment industry. Closely focusing on the pharmaceutical process, pharmaceutical engineering, and “GMP” requirements to develop, develop new products, improve new products, and meet the heavy responsibility of pharmaceutical manufacturing companies “GMP” transformation needs, naturally falls on the shoulders of the pharmaceutical equipment industry. During this period, the pharmaceutical equipment industry's product technology level, quality, full compliance with the "GMP" requirements and product variety specifications have significantly improved and developed, the industry as a whole has reached a new level.

Up till now, China has developed more than 800 pharmaceutical manufacturing enterprises with more than 3,000 kinds of product specifications. According to incomplete statistics, the annual production value is about RMB 15 billion, and the products not only fully meet the domestic and western pharmaceutical companies, animal pharmaceutical companies and health care products. In addition to the demand for goods and plants, it has also been exported to more than 60 countries and regions. Experts in the industry have analyzed that the urgent need for integration in the market and the urgent need for product innovation are the most pressing problems for the pharmaceutical equipment industry in China. Experts pointed out that although China's pharmaceutical equipment industry has made great achievements, many companies are still at the stage of imitation, improvement and combination at the technical level, and have not reached innovation or exceeded the level of similar products in the world. At present, the overall level of pharmaceutical equipment in China is worse than that of foreign pharmaceutical equipment by more than 10 years. The main reason for the slow development of China's pharmaceutical equipment technology level is that there are few talents in the pharmaceutical equipment industry in China. Pharmaceutical equipment is a special specialty, integrating pharmaceutical technology, biotechnology, chemical machinery, machinery and manufacturing processes, acoustics, optics, automation control, and computer application. The idea of ​​pharmaceutical equipment R&D is to apply these related majors throughout the entire design process. Nowadays, those who are engaged in the research and development of pharmaceutical equipment can skillfully take into account the two or three of them, and it is difficult for a single professional to inject these into the R&D concept. Professional elements. Some pharmaceutical equipment companies are competing to reduce prices, seriously affecting the development of the industry.

Now that some pharmaceutical equipment companies have entered the misunderstanding of competitive sales, there have been zero down payment, post-use payment, and sales below the cost price. The low product profitability has caused the company's cash flow to be difficult and it has been unable to invest in technology development and innovation. The technological progress of the industry has been adversely affected and health development has been unfavorable. Some companies have reduced the cost, cut corners and cut materials, and have deployed low-grade equipment. This has led to failures such as poor quality and poor after-sales service, which has reduced the international reputation of China's pharmaceutical equipment. The parameter setting and changes of pharmaceutical equipment process routes not only directly affect the quality and efficacy of drugs, but also directly affect the energy consumption, cost, economic benefits, and the health of operators. Due to the fact that quite a few manufacturers of pharmaceutical equipment do not have the experimental conditions, it is difficult to find the best process route and efficiency, and it is difficult to make the potential of the advanced nature of some pharmaceutical equipment not be available immediately and effectively. Experts pointed out that after the “GMP” certification, although the number of domestic pharmaceutical companies has decreased, the quality, production capacity and level, and product quality have greatly improved, and the demand for pharmaceutical machinery has also increased. Domestic pharmaceutical companies should give full play to their advantages and strengthen their strength in pre-sale and after-sales services. Enterprises can cooperate with some medical design institutes and research institutes to participate in new drug development and process improvement work of pharmaceutical companies, and win more customers by strengthening regular maintenance of equipment and training of customers. At the same time, enterprises should be good at seizing the opportunity of market differentiation, and increase their technological forces to research and develop equipment suitable for the manufacture of traditional Chinese medicine.

At present, the number of pharmaceutical equipment companies in China is numerous and uneven.

POLY LACE

Shiner Lace Fabric,100% Polyester Lace,Polyester Shiner Lace,Polyester Shiner Fabric

SHAOXING LANGDENG IMP&EXP CO.,LTD , https://www.ldfabric.com